151 related articles for article (PubMed ID: 12445306)
1. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
2. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
3. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
4. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.
McEvoy CR; Morley AA; Firgaira FA
Genes Chromosomes Cancer; 2003 Jul; 37(3):321-5. PubMed ID: 12759931
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
6. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
7. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
9. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
[TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
12. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA class I molecules assembled with structural variants of human beta2-microglobulin.
Trymbulak WP; Zeff RA
Immunogenetics; 1997; 46(5):418-26. PubMed ID: 9271632
[TBL] [Abstract][Full Text] [Related]
17. Criteria to define HLA haplotype loss in human solid tumors.
Ramal LM; Feenstra M; van der Zwan AW; Collado A; Lopez-Nevot MA; Tilanus M; Garrido F
Tissue Antigens; 2000 May; 55(5):443-8. PubMed ID: 10885565
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.
Chen HL; Gabrilovich D; Virmani A; Ratnani I; Girgis KR; Nadaf-Rahrov S; Fernandez-Viña M; Carbone DP
Int J Cancer; 1996 Sep; 67(6):756-63. PubMed ID: 8824545
[TBL] [Abstract][Full Text] [Related]
19. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
[TBL] [Abstract][Full Text] [Related]
20. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]